Synthesis and biological activities of novel danshensu amide derivatives as anti-myocardial ischemia agents

Latin American Journal of Pharmacy

Volumn 30, Issue 7, 2011, Pages 1355-1359

  Wang, Tingfang ^a,b   Shu, Jingjing ^a,b   Zheng, Liping ^a,b   Xiong, Liyan ^a   Wang, Jing ^a   Jin, Lei ^a   Wu, Qiuye ^a   Zou, Hao ^a   Zhang, Chuan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anti myocardial ischemia activities; Danshensu amide derivatives; Lipophilicity; Synthesis

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; 3 (3,4 DIMETHOXYPHENYL) 2 HYDROXY N METHYLPROPANAMIDE; 3 (3,4 DIMETHOXYPHENYL) 2 HYDROXY N PENTYLPROPANAMIDE; 3 (3,4 DIMETHOXYPHENYL) 2 HYDROXY N PROPYLPROPANAMIDE; 3 (3,4 DIMETHOXYPHENYL) N ETHYL 2 HYDROXYPROPANAMIDE; 3 (3,4 DIMETHOXYPHENYL) N HEXYL 2 HYDROXYPROPANAMIDE; CARDIOVASCULAR AGENT; METHYL 3 (3,4 DIHYDROXYPHENYL) 2 HYDROXYPROPANOATE; METHYL 3 (3,4 DIMETHOXYPHENYL) 2 HYDROXYPROPANOATE; N ALLYL 3 (3,4 DIMETHOXYPHENYL) 2 HYDROXYPROPANAMIDE; N BUTYL 3 (3,4 DIMETHOXYPHENYL) 2 HYDROXYPROPANAMIDE; PROPIONAMIDE DERIVATIVE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

AMINOLYSIS; ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL DAMAGE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG EFFECT; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HEART CELL CULTURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; LIPOPHILICITY; NONHUMAN; PLANT ROOT; RAT; RHIZOME; SALVIA MILTIORRHIZA; STRUCTURE ACTIVITY RELATION;

EID: 82355165054     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Liu, J. H.M. Shen & C.N. Ong (2001) Life Sci. 69: 1833-50.
2. Dong, Z.T. & W.D. Jiang (1982) Acta Pharm. Sin. 17: 226-8.
3. Lam, F.F.Y, J.H.K. Yeung, K.M. Chan & P.M.Y. Or (2007) Vasc Pharmacol. 46: 271-7.
4. Li, C.Z., S.C. Yang, F.D. Zhao, Y.Q. Yang, C.X. Yang & D.C. Zhang (1983) Zhongxiyi Jiehe Zazhi. 3: 297-9.
5. Heng, Z.H., Y.P. Lou, H.J. Dai, F. Xue et al. (1987) Shanghai Yike Daxue Xuebao 14: 25-9.
6. Tang, L.H., X.M. Wang & D.Q. Liang (1989) Zhongguo Bingli Shengli Zazhi 5: 65-9.
7. Le, X.Y., C.L. Chen, L. Ma, N. Zhao, Y.Q. Tang & X.Q. Liu (2008) Chinese. J. Nat. Med. 6: 461-5.
8. Liu, X.Q., X.T. Luo & X.A. Ouyang (2001) Shizhen Guoyi Guoyao. 12: 474-5.
9. Chan, K., S.H. Chui, D.Y.L. Wong, W.Y. Ha, C.L. Chan & R.N.S. Wong (2004) Life Sci. 75: 3157-71.
10. Zhao, G.R., H.M. Zhang, T.X. Ye, Z.J. Xiang, Y.J. Yuan, Z.X Guo et al. (2008) Food Chem. Toxicol. 46: 73-81.
11. Zhang N., H. Zou, L. Jin, J. Wang, M.F. Zhong, P. Huang et al. (2010) Acta Pharm. Sin. 31: 421-8.
12. Zhou, L.M., M.S.S. Chow & Z. Zuo (2009) Int J Pharm. 379: 109-18.
13. Dong, C.N., Y. Wang & Y.Z. Zhu (2009) Bioorg. Med. Chem. 17: 3499-507.
14. Zheng X.H., X.F. Zhao, Zhao X., S. X. Wang, Y. M. Wei & J. B. Zheng. (2007) J. Sep. Sci. 30: 851-7.
15. Wang S.P., W.J. Zang, X.H. Zheng, S.S. Kong, X.J. Yu, L. Sun et al. (2008) Eur. J. Pharmacol. 579: 283-8.
16. Zhang, C., H. Zou & N. Zhang (2008) China Pat. CN101289385(A).
17. Vyas, G.N. & N.M. Shah (1963) Org. Synth. Collect. IV: 836.
18. Li, Y., Y. Bao, B. Jiang, Z. Wang, Y. Liu, C. Zhang et al. (2008) Int. J. Devl. Neurosci. 26: 309-17.
19. Xia, Y., Z. W. Dong, B.X. Zhao, X. Ge, N. Meng, D.S. Shin et al. (2007) Bioorg. Med. Chem. 15: 6893-9.
20. Roleira, F.M.F., C. Siquet, E. Orrù, E.M. Garrido, J. Garrido, N. Milhazes et al. (2010) Bioorg. Med. Chem. 18: 5816-25.
21. Molinspiration, Cheminformatics, Bratislava, Slovak Republic. Available at < http://www.molinspiration.com/services/properties.html>.
22. Hansch, C., J.P. Björkroth and A. Leo (1987) J. Pharm. Sci. 76: 663-87.